HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Tasurgratinib

HCID 78323434
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1622204-21-0
Standard SMILES
CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(CCO)CC5)cc4)c3)c(OCCOC)cc21
InChIKey
IBHOLSBDZMIPPT-UHFFFAOYSA-N
Molecular formula
C32H37N5O6
Average molar mass
587.7 g/mol
Monoisotopic mass
587.27438392

Overview

Tasurgratinib is a small molecule drug. The usage of the INN stem '-gratinib' in the name indicates that Tasurgratinib is a fibroblast growth factor receptor (FGFR) inhibitor. Tasurgratinib is under investigation in clinical trial NCT04962867 (NCCH2006/MK010 Trial (FORTUNE Trial)). Tasurgratinib has a monoisotopic molecular weight of 587.27 Da.

Names & identifiers

Preferred name
Tasurgratinib
IUPAC
5-[[2-[[4-[1-(2-hydroxyethyl)piperidin-4-yl]benzoyl]amino]-4-pyridinyl]oxy]-6-(2-methoxyethoxy)-N-methylindole-1-carboxamide
English name
E-7090
Molecular formula
C32H37N5O6
Molecular weight
587.67

Names & synonyms

E-7090tasurgratinibTN7CUD1NGAUNII-TN7CUD1NGATASURGRATINIB [INN]E 7090Tasurgratinib (INN)5-[2-[[4-[1-(2-hydroxyethyl)piperidin-4-yl]benzoyl]amino]pyridin-4-yl]oxy-6-(2-methoxyethoxy)-N-methylindole-1-carboxamideExample 22 [WO2014129477A1]Example 22 (WO2014129477A1)5-(2-((4-(1-(2-hydroxyethyl)piperidin-4-yl)benzoyl)amino)pyridin-4-yl)oxy-6-(2-methoxyethoxy)-N-methylindole-1-carboxamideRefChem:187502
Show more names
E7090 (E 7090)1H-Indole-1-carboxamide, 5-[[2-[[4-[1-(2-hydroxyethyl)-4-piperidinyl]benzoyl]amino]-4-pyridinyl]oxy]-6-(2-methoxyethoxy)-N-methyl-
E-7090 [WHO-DD]1-(2-HYDROXYETHYL)-7-(2-METHOXYETHOXY)-N-METHYL-3-OXO-7H-6-OXA-4-AZA-7(5)-INDOLA-5(2,4)-PYRIDINA-1(4)-PIPERIDINA-2(1,4)-BENZENAHEPTAPHANE-7-CARBOXAMIDE1622204-21-0E7090Fgf/fgfr pathway inhibitor E70905-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamido)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide1H-Indole-1-carboxamide, 5-((2-((4-(1-(2-hydroxyethyl)-4-piperidinyl)benzoyl)amino)-4-pyridinyl)oxy)-6-(2-methoxyethoxy)-N-methyl-5-((2-(((4-(1-(2-Hydroxyethyl)piperidin-4-yl)phenyl)carbonyl)amino)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide

Properties

Computed structural propertiesFilling in

XLogP
3.1
Topological polar surface area
127 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
8
Rotatable bonds
11
Heavy atoms
43
Formal charge
0
Complexity
880

Physicochemical properties

form
Solid
color
White to off-white
FDA UNII
7 CUD1NGA · TN7CUD1NGA

Chemistry & industry

Applications

UsesE7090 is an orally available, potent, and selective FGFR inhibitor with IC50s of 0.71 nM, 0.50 nM, 1.2 nM, and 120 nM for FGFR1/FGFR2/FGFR3/FGFR4, respectively[1].

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
1622204-21-0
PubChem CID
78323434
ChEMBL
CHEMBL3686884
UNII
TN7CUD1NGA
Nikkaji
J3.445.819G